H.C. Wainwright Sticks to Their Hold Rating for CytomX Therapeutics (CTMX)

TipRanksSep 13 18:17 · Ratings

Express News | CytomX Therapeutics Announces First Patient Dosed With Cx-801, a Dually-Masked Interferon-Alpha 2B Probody®, in a Phase 1 Study in Patients With Solid Tumors

BreakingsSep 9 20:00

CytomX Therapeutics Announces First Patient Dosed With CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY, in a Phase 1 Study in Patients With Solid Tumors

Yahoo FinanceSep 9 20:00

CytomX Therapeutics to Present at Upcoming September Investor Conferences

GlobeNewswireSep 4 20:00

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX)

TipRanksAug 22 21:20 · Ratings

HC Wainwright & Co. Reiterates Neutral on CytomX Therapeutics

BenzingaAug 22 19:31